Cheung CMG, Lee WK, Koizumi H et al (2019) Pachychoroid disease. Eye 33:14–33. https://doi.org/10.1038/s41433-018-0158-4

Article  PubMed  Google Scholar 

Warrow DJ, Hoang QV, Freund KB (2013) Pachychoroid pigment epitheliopathy. Retina 33:1659–1672. https://doi.org/10.1097/IAE.0b013e3182953df4

Article  PubMed  Google Scholar 

Pang CE, Freund KB (2015) Pachychoroid neovasculopathy. Retina 35:1–9. https://doi.org/10.1097/IAE.0000000000000331

Article  CAS  PubMed  Google Scholar 

Azuma K, Tan X, Asano S et al (2019) The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy. PLoS One 14:e0212055. https://doi.org/10.1371/journal.pone.0212055

Article  CAS  PubMed Central  PubMed  Google Scholar 

Matsumoto H, Hiroe T, Morimoto M et al (2018) Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration. Jpn J Ophthalmol 62:144–150. https://doi.org/10.1007/s10384-018-0562-0

Article  CAS  PubMed  Google Scholar 

Kinoshita T, Mori J, Hatanaka A et al (2021) Visual outcome and treatment frequency of Anti-VEGF therapy using the treat-and-extend and treatment cessation regimen for exudative age-related macular degeneration and pachychoroid neovasculopathy. Clin Ophthalmol 15:4405–4418. https://doi.org/10.2147/OPTH.S334641

Article  CAS  PubMed Central  PubMed  Google Scholar 

Hata M, Tagawa M, Oishi A et al (2019) Efficacy of photodynamic therapy for polypoidal choroidal vasculopathy associated with and without pachychoroid phenotypes. Ophthalmol Retina 3:1016–1025. https://doi.org/10.1016/j.oret.2019.06.013

Article  PubMed  Google Scholar 

Azuma K, Okubo A, Nomura Y et al (2020) Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy. Sci Rep 10:8337. https://doi.org/10.1038/s41598-020-65346-w

Article  CAS  PubMed Central  PubMed  Google Scholar 

Tanaka K, Mori R, Wakatsuki Y et al (2021) Two-thirds dose photodynamic therapy for pachychoroid neovasculopathy. J Clin Med 10:2168. https://doi.org/10.3390/jcm10102168

Article  PubMed Central  PubMed  Google Scholar 

Sacconi R, Tomasso L, Corbelli E et al (2019) Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study. Eye 33:1809–1817. https://doi.org/10.1038/s41433-019-0511-2

Article  CAS  PubMed Central  PubMed  Google Scholar 

Hikichi T, Kubo N, Yamauchi M (2021) One-year comparison of anti-vascular endothelial growth factor and half-dose photodynamic therapies for pachychoroid neovasculopathy. Eye 35:3367–3375. https://doi.org/10.1038/s41433-021-01418-z

Article  CAS  PubMed Central  PubMed  Google Scholar 

Yamashiro K, Yanagi Y, Koizumi H et al (2022) Relationship between pachychoroid and polypoidal choroidal vasculopathy. J Clin Med 11:4614. https://doi.org/10.3390/jcm11154614

Article  PubMed Central  PubMed  Google Scholar 

Roy R, Saurabh K, Shah D, Goel S (2019) Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor. Indian J Ophthalmol 67:1678–1683. https://doi.org/10.4103/ijo.IJO_1481_18

Article  PubMed Central  PubMed  Google Scholar 

Matsumoto H, Mukai R, Kikuchi Y et al (2020) One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions. Jpn J Ophthalmol 64:203–209. https://doi.org/10.1007/s10384-020-00722-7

Article  CAS  PubMed  Google Scholar 

Kitajima Y, Maruyama-Inoue M, Ito A et al (2020) One-year outcome of combination therapy with intravitreal anti-vascular endothelial growth factor and photodynamic therapy in patients with pachychoroid neovasculopathy. Graefes Arch Clin Exp Ophthalmol 258:1279–1285. https://doi.org/10.1007/s00417-020-04661-4

Article  CAS  PubMed  Google Scholar 

Sartini F, Figus M, Casini G et al (2020) Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum-pathogenesis, imaging and available treatment options. Int Ophthalmol 40:3577–3589. https://doi.org/10.1007/s10792-020-01522-1

Article  PubMed  Google Scholar 

Karasu B, Celebi ARC (2021) An efficacy comparison of combination of different anti-vascular endothelial growth factors and photodynamic therapy in patients with pachychoroid neovasculopathy. Int Ophthalmol 41:1989–2000. https://doi.org/10.1007/s10792-021-01754-9

Article  PubMed  Google Scholar 

Miki A, Kusuhara S, Otsuji T et al (2021) Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy. PLoS One 16:e0248760. https://doi.org/10.1371/journal.pone.0248760

Article  CAS  PubMed Central  PubMed  Google Scholar 

Sato-Akushichi M, Ono S, Taneda T et al (2022) One-year outcome of combination therapy with full or reduced photodynamic therapy and one anti-vascular endothelial growth factor in pachychoroid neovasculopathy. Pharm Basel Switz 15:483. https://doi.org/10.3390/ph15040483

Article  Google Scholar 

Takeuchi J, Ota H, Nakano Y et al (2023) Predictive factors for outcomes of half-dose photodynamic therapy combined with aflibercept for pachychoroid neovasculopathy. Graefes Arch Clin Exp Ophthalmol 261:2235–2243. https://doi.org/10.1007/s00417-023-06030-3

Article  CAS  PubMed  Google Scholar 

Hikichi T, Kubo N, Tabata M, Kurabe H (2023) Enlargement of choroidal neovascularization before recurrence after photodynamic therapy for pachychoroid neovasculopathy. Retina. https://doi.org/10.1097/IAE.0000000000003841

Article  PubMed  Google Scholar 

Tanaka N, Azuma K, Aoki S et al (2024) Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-024-06387-z

Article  PubMed  Google Scholar 

Hata M, Yamashiro K, Ooto S et al (2017) intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 58:292–298. https://doi.org/10.1167/iovs.16-20967

Article  CAS  PubMed  Google Scholar 

Park JB, Kim K, Kang MS et al (2022) Central serous chorioretinopathy: Treatment. Taiwan J Ophthalmol 12:394–408. https://doi.org/10.4103/2211-5056.362040

Article  PubMed Central  PubMed  Google Scholar 

Tagawa M, Ooto S, Yamashiro K et al (2020) Characteristics of pachychoroid neovasculopathy. Sci Rep 10:16248. https://doi.org/10.1038/s41598-020-73303-w

Article  CAS  PubMed Central  PubMed  Google Scholar 

Elfandi S, Ooto S, Miyata M et al (2021) Effects of intravitreous aflibercept injection in pachychoroid neovasculopathy: Comparison with typical neovascular age-related macular degeneration. Clin Ophthalmol 15:1539–1549. https://doi.org/10.2147/OPTH.S285257

Article  PubMed Central  PubMed  Google Scholar 

Tanaka K, Oguchi Y, Omori T et al (2021) Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease. Sci Rep 11:8464. https://doi.org/10.1038/s41598-021-87340-6

Article  CAS  PubMed Central  PubMed  Google Scholar 

Spaide RF (2018) Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina 38:708–716. https://doi.org/10.1097/IAE.0000000000001689

Article  PubMed  Google Scholar 

Fung AT, Yannuzzi LA, Freund KB (2012) Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina 32:1829–1837. https://doi.org/10.1097/IAE.0b013e3182680a66

Article  PubMed  Google Scholar 

Dansingani KK, Balaratnasingam C, Klufas MA et al (2015) Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 160:1243-1254.e2. https://doi.org/10.1016/j.ajo.2015.08.028

Article  PubMed  Google Scholar 

Miyake M, Ooto S, Yamashiro K et al (2015) Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep 5:16204. https://doi.org/10.1038/srep16204

Article  CAS  PubMed Central  PubMed  Google Scholar 

Bressler NM (1960) Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol Chic Ill 119:198–207

Google Scholar 

Nomura Y, Takahashi H, Tan X et al (2014) Effects of vitreomacular adhesion on ranibizumab treatment in Japanese patients with age-related macular degeneration. Jpn J Ophthalmol 58:443–447. https://doi.org/10.1007/s10384-014-0333-5

Article  CAS  PubMed  Google Scholar 

Betzler BK, Ding J, Wei X et al (2022) Choroidal vascularity index: a step towards software as a medical device. Br J Ophthalmol 106:149–155. https://doi.org/10.1136/bjophthalmol-2021-318782